{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:53:19Z","timestamp":1793245999836,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007833","name":"Hamad Medical Corporation","doi-asserted-by":"publisher","award":["MRC-1-21-503"],"award-info":[{"award-number":["MRC-1-21-503"]}],"id":[{"id":"10.13039\/100007833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020643","name":"Medical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020643","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jid.2025.08.003","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T08:17:11Z","timestamp":1755505031000},"page":"711-721.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cathelicidin LL-37-Induced Transcriptome of Human Keratinocyte Identifies Chemokine CXCL10 Link to T-Cell-Mediated Rosacea Pathogenesis through Jak1\/STAT1 Pathway"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0015-9834","authenticated-orcid":false,"given":"Abdul W.","family":"Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanwir","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fareed","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thesni","family":"Raheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia S.","family":"Elizabeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Al-Harami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh","family":"Jochebeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7090-2187","authenticated-orcid":false,"given":"Martin","family":"Steinhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2025.08.003_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.556579","article-title":"Azithromycin differentially alters TCR-activated helper T cell subset phenotype and effector function","volume":"11","author":"Ansari","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.08.003_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3078194","article-title":"Saliva-derived host defense peptides Histatin1 and LL-37 increase secretion of antimicrobial skin and oral mucosa chemokine CCL20 in an IL-1\u03b1-independent manner","volume":"2017","author":"Boink","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jid.2025.08.003_bib3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0190-9622(93)70065-2","article-title":"The Demodex mite population in rosacea","volume":"28","author":"Bonnar","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaad.2014.01.892","article-title":"Comparative analysis of rosacea and cutaneous lupus erythematosus: histopathologic features, T-cell subsets, and plasmacytoid dendritic cells","volume":"71","author":"Brown","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib5","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1016\/j.jid.2022.01.015","article-title":"Ruxolitinib cream in the treatment of cutaneous Lichen Planus: a prospective, open-label study","volume":"142","author":"Brumfiel","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib6","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.16537.1","article-title":"Recent advances in understanding and managing rosacea","volume":"7","author":"Buddenkotte","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.jid.2025.08.003_bib7","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2015.141","article-title":"Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1\/Th17 pathways","volume":"135","author":"Buhl","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib8","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2024.2397477","article-title":"Janus kinase inhibitors and adverse events of acne in dermatologic indications: a systematic review and network meta-analysis","volume":"35","author":"Chen","year":"2024","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jid.2025.08.003_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109011","article-title":"Thalidomide ameliorates rosacea-like skin inflammation and suppresses NF-\u03baB activation in keratinocytes","volume":"116","author":"Chen","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jid.2025.08.003_bib10","article-title":"POSTN silencing ameliorates LL37-induced rosacea and inhibits the JAK2\/STAT3 and NF-\u03baB pathways","volume":"39","author":"Chen","year":"2025","journal-title":"FASEB J"},{"key":"10.1016\/j.jid.2025.08.003_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12026-007-8014-9","article-title":"Th17 cells: a new fate for differentiating helper T cells","volume":"41","author":"Chen","year":"2008","journal-title":"Immunol Res"},{"key":"10.1016\/j.jid.2025.08.003_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1124\/mol.59.4.707","article-title":"Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states","volume":"59","author":"Cox","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jid.2025.08.003_bib13","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.4049\/jimmunol.172.2.1146","article-title":"The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization","volume":"172","author":"Davidson","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2025.08.003_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.674871","article-title":"Keratinocyte-immune cell crosstalk in a STAT1-mediated pathway: novel insights into rosacea pathogenesis","volume":"12","author":"Deng","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.08.003_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/1096-9896(200108)194:4<397::AID-PATH899>3.0.CO;2-S","article-title":"Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation","volume":"194","author":"Flier","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.jid.2025.08.003_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/jidsymp.2011.9","article-title":"Rosacea: the cytokine and chemokine network","volume":"15","author":"Gerber","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jid.2025.08.003_bib17","first-page":"282","article-title":"Incidence and prevalence of rosacea: a systematic review and meta-analysis","volume":"179","author":"Gether","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib18","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1093\/emboj\/18.20.5601","article-title":"p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons","volume":"18","author":"Goh","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.jid.2025.08.003_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2025.2452987","article-title":"Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis","volume":"36","author":"Grote","year":"2025","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jid.2025.08.003_bib20","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250049","article-title":"Topical JAK inhibitor for refractory skin inflammation in STAT1 GOF","volume":"1","author":"Guarnieri","year":"2025","journal-title":"J Hum Immun"},{"key":"10.1016\/j.jid.2025.08.003_bib21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1432-1033.1996.0325z.x","article-title":"The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes","volume":"238","author":"Gudmundsson","year":"1996","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jid.2025.08.003_bib22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00011-010-0192-6","article-title":"Dipyrithione inhibits IFN-gamma-induced JAK\/STAT1 signaling pathway activation and IP-10\/CXCL10 expression in RAW264.7 cells","volume":"59","author":"Han","year":"2010","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jid.2025.08.003_bib23","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jid.2020.08.013","article-title":"Paired transcriptomic and proteomic analysis implicates IL-1\u03b2 in the pathogenesis of papulopustular rosacea explants","volume":"141","author":"Harden","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/09546634.2019.1624683","article-title":"Rosacea associated with dupilumab therapy","volume":"32","author":"Heibel","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jid.2025.08.003_bib25","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood-2004-06-2435","article-title":"Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage","volume":"105","author":"Hirakawa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jid.2025.08.003_bib26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/exd.13143","article-title":"Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics","volume":"26","author":"Holmes","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1468-3083.2010.03825.x","article-title":"Immunohistochemical expression of matrix metalloproteinases in the granulomatous rosacea compared with the non-granulomatous rosacea","volume":"25","author":"Jang","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2025.08.003_bib28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142067","article-title":"Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin","volume":"5","author":"Jiang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2025.08.003_bib29","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jaad.2021.01.012","article-title":"Facial and neck erythema associated with dupilumab treatment: a systematic review","volume":"84","author":"Jo","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib30","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/eji.200636420","article-title":"IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes","volume":"37","author":"Kanda","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2025.08.003_bib31","doi-asserted-by":"crossref","first-page":"W212","DOI":"10.1093\/nar\/gkz446","article-title":"ChEA3: transcription factor enrichment analysis by orthogonal omics integration","volume":"47","author":"Keenan","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2025.08.003_bib32","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1172\/JCI17545","article-title":"An angiogenic role for the human peptide antibiotic LL-37\/hCAP-18","volume":"111","author":"Koczulla","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jid.2025.08.003_bib33","first-page":"420","article-title":"Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea","volume":"179","author":"Lacey","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib34","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W","article-title":"Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization","volume":"28","author":"Loetscher","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2025.08.003_bib35","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jamadermatol.2023.3830","article-title":"Janus kinase inhibitors and adverse events of acne: a systematic review and meta-analysis","volume":"159","author":"Martinez","year":"2023","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1600-0625.2011.01325.x","article-title":"Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum","volume":"20","author":"Murakami","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib37","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1038\/jid.2014.222","article-title":"Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea","volume":"134","author":"Muto","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib38","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1182\/blood-2004-07-2656","article-title":"TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment","volume":"106","author":"Orinska","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jid.2025.08.003_bib39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41416-025-02956-z","article-title":"Enhanced CXCL10 expression in mast cells for cutaneous neurofibroma presenting with pain and itch","volume":"132","author":"Pham","year":"2025","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jid.2025.08.003_bib41","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.2147\/CCID.S440138","article-title":"Successful treatment of granulomatous rosacea by JAK inhibitor abrocitinib: a case report","volume":"16","author":"Ren","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib42","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2025.08.003_bib43","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.ddmec.2013.01.001","article-title":"Innate immunity and the role of the antimicrobial peptide cathelicidin in inflammatory skin disease","volume":"10","author":"Roby","year":"2013","journal-title":"Drug Discov Today Dis Mech"},{"key":"10.1016\/j.jid.2025.08.003_bib44","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jaad.2017.02.049","article-title":"Treatment of vitiligo with the topical Janus kinase inhibitor Ruxolitinib","volume":"76","author":"Rothstein","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib45","first-page":"1","article-title":"T-cell subsets in acne rosacea lesions and the possible role of demodex folliculorum","volume":"169","author":"Rufli","year":"1984","journal-title":"Dermatologica"},{"key":"10.1016\/j.jid.2025.08.003_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jdermsci.2014.09.002","article-title":"Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible implications for rosacea","volume":"76","author":"Salzer","year":"2014","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jid.2025.08.003_bib47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaci.2008.03.027","article-title":"Antimicrobial peptides and the skin immune defense system","volume":"122","author":"Schauber","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2025.08.003_bib48","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","article-title":"Clinical, cellular, and molecular aspects in the pathophysiology of rosacea","volume":"15","author":"Steinhoff","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jid.2025.08.003_bib49","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jaad.2013.04.045","article-title":"New insights into rosacea pathophysiology: a review of recent findings","volume":"69","author":"Steinhoff","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib50","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00403-024-03314-4","article-title":"The treatment of tofacitinib for rosacea through the inhibition of the JAK\/STAT signaling pathway","volume":"316","author":"Sun","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2025.08.003_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15848","article-title":"Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: a retrospective case series","volume":"35","author":"Sun","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jid.2025.08.003_bib52","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"Szklarczyk","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jid.2025.08.003_bib53","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jaad.2013.04.043","article-title":"Rosacea: current state of epidemiology","volume":"69","author":"Tan","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib54","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1523-1747.1999.00581.x","article-title":"Human IP-9: a keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10\/Mig receptor (CXCR3)","volume":"112","author":"Tensen","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib55","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s13555-025-01382-6","article-title":"Palmoplantar pustulosis as an immune-mediated inflammatory disease with a possible relevance of Th17 cell plasticity: a narrative review","volume":"15","author":"Terui","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jid.2025.08.003_bib56","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.4049\/jimmunol.165.6.3058","article-title":"Disparate cytotoxic activity of nickel-specific CD8+ and CD4+ T cell subsets against keratinocytes","volume":"165","author":"Traidl","year":"2000","journal-title":"J Immunol. England"},{"key":"10.1016\/j.jid.2025.08.003_bib57","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","article-title":"Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors","volume":"72","author":"Two","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib58","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMcp1506630","article-title":"Rosacea","volume":"377","author":"van Zuuren","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2025.08.003_bib59","article-title":"Complete resolution of granulomatous rosacea with topical Ruxolitinib","volume":"17","author":"Weiner","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.jid.2025.08.003_bib60","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jaad.2025.04.020","article-title":"Efficacy and safety of oral JAK1 inhibitor upadacitinib monotherapy for papulopustular rosacea: a real-world study","volume":"93","author":"Xu","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib61","article-title":"JAK1 inhibitor abrocitinib for the treatment of steroid-induced rosacea: case series","volume":"10","author":"Xu","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2025.08.003_bib62","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2025.08.003_bib63","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/jidsymp.2011.4","article-title":"Rosacea as a disease of cathelicidins and skin innate immunity","volume":"15","author":"Yamasaki","year":"2011","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jid.2025.08.003_bib64","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/jid.2010.351","article-title":"TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes","volume":"131","author":"Yamasaki","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib65","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.192.7.1069","article-title":"LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells","volume":"192","author":"Yang","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.jid.2025.08.003_bib66","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.jid.2021.02.745","article-title":"Antimicrobial peptide LL-37 drives rosacea-like skin inflammation in an NLRP3-dependent manner","volume":"141","author":"Yoon","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2025.08.003_bib67","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/C5MB00663E","article-title":"ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization","volume":"12","author":"Yu","year":"2016","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.jid.2025.08.003_bib68","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.jid.2025.08.003_bib69","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/bioinformatics\/btu684","article-title":"DOSE: an R\/Bioconductor package for disease ontology semantic and enrichment analysis","volume":"31","author":"Yu","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jid.2025.08.003_bib70","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.4049\/jimmunol.179.11.7684","article-title":"Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways","volume":"179","author":"Yu","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2025.08.003_bib71","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1189\/jlb.0403147","article-title":"Cathelicidins, multifunctional peptides of the innate immunity","volume":"75","author":"Zanetti","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jid.2025.08.003_bib72","article-title":"Treatment of rosacea with upadacitinib and abrocitinib: case report and review of evidence for Janus kinase inhibition in rosacea","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2025.08.003_bib74","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat Commun"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25023437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X25023437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T04:29:42Z","timestamp":1779942582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X25023437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0022202X25023437"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2025.08.003","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cathelicidin LL-37-Induced Transcriptome of Human Keratinocyte Identifies Chemokine CXCL10 Link to T-Cell-Mediated Rosacea Pathogenesis through Jak1\/STAT1 Pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2025.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}